| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.2 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.2 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.067 | 0.2 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | -0.044 | 0.3 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | 0.043 | 0.3 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.045 | 0.3 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.044 | 0.3 |